Target intelligence / Profile preview

Teneurin transmembrane protein 4 (TENM4)

Target
TENM4
Molecular classification
Single-pass type II transmembrane protein, Cell adhesion molecule, Other (Teneurin family)
01

Overview

Teneurin transmembrane protein 4 (TENM4) is a large, evolutionary conserved, single-pass type II transmembrane protein predominantly expressed in the nervous system. It is a member of the teneurin family of cell adhesion molecules crucial for neural development, mediating cell-cell and synaptic interactions, and axon guidance. Structurally, TENM4 possesses domains such as EGF-like, YD repeats, and beta-propeller, contributing to its adhesive and signaling functions. TENM4 regulates neurodevelopmental processes, including synaptic partner matching and oligodendrocyte differentiation, and its loss of function is associated with defects in neuronal connectivity and hereditary essential tremor 5. In cancer, TENM4 is recurrently rearranged or fused with genes such as NRG1 to generate oncoproteins (e.g., γ-heregulin), and its expression can be epigenetically regulated. There is emerging evidence of its role in multiple cancer types, but it is not a current therapeutic drug target, nor are drugs specifically known to modulate its function[1][2][3][4][5][6].

Other names
Teneurin-4ODZ4KIAA1302DOC4Protein Odd Oz/ten-m homolog 4Tenascin-M4downstream of CHOP 4Ten-4Ten-M4TNM4ETM5Ten-m4odz
02

Biological functions

Neural developmentCell adhesionAxon guidanceSynaptic connectivityOligodendrocyte differentiation and myelinationSignal transduction
03

Disease associations

Essential tremor (hereditary essential tremor 5)Cancer (involvement via gene rearrangements/fusions, especially in breast, ovarian, and pancreatic cancers)Neurodevelopmental disorders (putative)
04

Safety considerations

Potential for oncogenic fusion proteins in cancer (such as TENM4-NRG1/γ-heregulin fusion)Wide expression in the brain suggests possible CNS-related safety considerations
05

Biomarkers

TENM4-NRG1 gene fusion (γ-heregulin) as a biomarker for a subset of breast and pancreatic tumors

Beyond the preview

Go deeper on Teneurin transmembrane protein 4 (TENM4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Teneurin transmembrane protein 4 (TENM4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call